Chesapeake Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Chesapeake Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06K	Hold	25	–	–	﹤0.01%	364
2026 Q1	$664	Hold	25	–	–	﹤0.01%	316
2025 Q4	$728	Hold	25	–	–	﹤0.01%	339
2025 Q3	$698	Hold	25	–	–	﹤0.01%	297
2025 Q2	$612	Hold	25	–	–	﹤0.01%	306
2025 Q1	$522	Hold	25	–	–	﹤0.01%	433
2024 Q4	$592	Hold	25	–	–	﹤0.01%	377
2024 Q3	$644	Hold	25	–	–	﹤0.01%	348
2024 Q2	$590	Hold	25	–	–	﹤0.01%	307
2024 Q1	$723	Sell	25 -140	-85%	-$4.21K	﹤0.01%	292
2023 Q4	$5.42K	Hold	165	–	–	﹤0.01%	290
2023 Q3	$4.6K	Hold	165	–	–	﹤0.01%	322
2023 Q2	$5.63K	Hold	165	–	–	0.01%	298
2023 Q1	$4.97K	Buy	+165	New	+$5.11K	﹤0.01%	304

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Chesapeake Asset Management's ARKG Position: Q2 2026 in Review

Chesapeake Asset Management held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 25 shares worth $1.06K. The position accounts for ﹤0.01% of the portfolio, ranked #364.

Chesapeake Asset Management first reported a position in ARKG in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.63K in Q2 2023. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Chesapeake Asset Management held 25 shares of ARK Genomic Revolution ETF worth $1.06K as of Q2 2026.
Chesapeake Asset Management left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Chesapeake Asset Management's portfolio in Q2 2026, its #364 holding.
Chesapeake Asset Management first reported a position in ARK Genomic Revolution ETF in Q1 2023 and has held it in 14 quarters since.
Chesapeake Asset Management's ARK Genomic Revolution ETF position peaked at $5.63K in Q2 2023.
271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Chesapeake Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.